Enlivex Ltd. – Filings and Transcripts

NASDAQ: ENLV
Share price (5/22/26): $0.72
Market cap (5/22/26): $173 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Prospectus supplement

Registration of securities for employees

Prospectus supplement

Ownership Filter

Hershkovitz Oren

Shlosberger Shachar

Pomerantz Roger

News Filter

Announces Dosing of First Patient in the United States as Part of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-To-Severe Knee Osteoarthritis

Announces Receipt of Nasdaq Minimum Bid Price Notification

Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-To-Severe Knee Osteoarthritis

Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares

Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone to Create a Prediction Market via a Single Prompt

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness